MireyaPaulinaVelasquezMD

Pediatric Hematology & Oncology • Memphis, TN

Clinical Postdoc Fellow, Pediatric Hematology & Oncology, Baylor College of Medicine

Join to view full profile

Dr. Velasquez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Velasquez's full profile

Already have an account?

Office
262 Danny Thomas Pl MS 310
Memphis, TN 38105
Phone+1 901-595-6528

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Baylor College of Medicine (Houston)Residency, Pediatrics, 2008 - 2011
Universidiad Francisco Marroquin Faculty of MedicineClass of 2006

Certifications & Licensure

TN State Medical License 2018 - 2026
TX State Medical License 2014 - 2026
UT State Medical License 2011 - 2012
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

9 citations
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models.
Hong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, Abishek Vaidya, Challice L Bonifant
Frontiers in Immunology. 2022-01-01
146 citations
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.
Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen, Yiping Fan, Alejandro Allo Anido
Science Translational Medicine. 2021-11-17
1 citations
Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
Patrick Schreiner, Mireya Paulina Velasquez, Stephen Gottschalk, Jinghui Zhang, Yiping Fan
Oncoimmunology. 2021-01-01

Abstracts/Posters

Transgenic Expression of IL15 in CD123-Specific BiTE-Secreting Engager T-Cells Results in Improved Anti-AML Activity
Mireya Paulina Velasquez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells
Mireya Paulina Velasquez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia
Mireya Paulina Velasquez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019